about
STAT3: A Novel Molecular Mediator of Resistance to ChemoradiotherapyPolymeric Nanoparticles to Combat Squamous Cell Carcinomas in Patients with Dystrophic Epidermolysis Bullosa.Controversies in the diagnosis and treatment of early cutaneous melanoma.Surgical management of noncolorectal cancer liver metastases.Excision of fascia in melanoma thicker than 2 mm: no evidence for improved clinical outcome.Expression and clinicopathological significance of microRNA-21 and programmed cell death 4 in malignant melanoma.
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Managing malignant melanoma.
@en
type
label
Managing malignant melanoma.
@en
prefLabel
Managing malignant melanoma.
@en
P1476
Managing malignant melanoma.
@en
P2093
William W Dzwierzynski
P304
P356
10.1097/PRS.0B013E31829AD411
P407
P577
2013-09-01T00:00:00Z